5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-8
Abstract
Objective. The serotonin (5-HT) pathway was shown to play a role in pulmonary hypertension (PH), but its functions in right ventricular failure (RVF) remain poorly understood. The aim of the current study was to investigate the effects of Terguride (5-HT2A and 2B receptor antagonist) or SB204741 (5-HT2B receptor antagonist) on right heart function and structure upon pulmonary artery banding (PAB) in mice.Methods. Seven days after PAB, mice were treated for 14 days with Terguride (0.2 mg/kg bid) or SB204741 (5 mg/kg day). Right heart function and remodeling were assessed by right heart catheterization, magnetic resonance imaging (MRI), and histomorphometric methods. Total secreted collagen content was determined in mouse cardiac fibroblasts isolated from RV tissues.Results. Chronic treatment with Terguride or SB204741 reduced right ventricular fibrosis and showed improved heart function in mice after PAB. Moreover, 5-HT2B receptor antagonists diminished TGF-beta1 induced collagen synthesis of RV cardiac fibroblastsin vitro.Conclusion. 5-HT2B receptor antagonists reduce collagen deposition, thereby inhibiting right ventricular fibrosis. Chronic treatment prevented the development and progression of pressure overload-induced RVF in mice. Thus, 5-HT2B receptor antagonists represent a valuable novel therapeutic approach for RVF.Keywords
Funding Information
- Universities of Giessen and Marburg Lung Centre
This publication has 37 references indexed in Scilit:
- Serotonin paracrine signaling in tissue fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Deletion of Fn14 receptor protects from right heart fibrosis and dysfunctionBasic Research in Cardiology, 2013
- Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2Areceptors involved in the pulmonary artery remodeling of pulmonary artery hypertensionExperimental Lung Research, 2013
- Serotonin Potentiates Transforming Growth Factor-beta3 Induced Biomechanical Remodeling in Avian Embryonic Atrioventricular ValvesPLOS ONE, 2012
- The Pharmacological Treatment of Pulmonary Arterial HypertensionPharmacological Reviews, 2012
- Serotonin 5-HT 2B Receptor in Cardiac Fibroblast Contributes to Cardiac HypertrophyCirculation Research, 2009
- Serotonin 5-HT 2B Receptor Blockade Prevents Reactive Oxygen Species–Induced Cardiac Hypertrophy in MiceHypertension, 2008
- Cor Pulmonale: An OverviewSeminars in Respiratory and Critical Care Medicine, 2003
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Diagnosis and Drug Therapy of ProlactinomaDrugs, 1996